Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Active, not recruiting · NCT06993610 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense | Acneiform Eruptions, Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, acne, bacterial infectious disease, dermatitis, hidradenitis, hidradenitis suppurativa, sebaceous gland disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Active, not recruiting | Phase 2 | 2026-06-30 | NCT06993610 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zura Bio Inc | 2 |
61 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.